Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check12 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check19 days agoChange DetectedThe study record now indicates that results are posted, including an Adverse Events section, and reflects updated study status and contacts/locations. A new version dated 2026-09-03 was added to the record history.SummaryDifference0.3%

- Check33 days agoChange DetectedThe record history now shows the latest revision as v3.7.0, replacing the previous v3.6.6. This updates the revision label used in the study record history.SummaryDifference0.0%

- Check55 days agoChange DetectedVersion 64 was added on 2026-07-31, introducing a Quality Control status Has Not Concluded and new entries for Adverse Events and Study Status. The record now shows a Returned date of 2026-08-24 and a revision update to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.3%

- Check76 days agoChange DetectedRevision indicator updated from v3.6.4 to v3.6.5 on the page, indicating a newer build of the interface. This is a minor update to the site's metadata rather than a change to study content.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.